These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial. Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885 [TBL] [Abstract][Full Text] [Related]
31. Actinic keratosis - review for clinical practice. de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357 [TBL] [Abstract][Full Text] [Related]
32. Current treatments of actinic keratosis. Gold MH; Nestor MS J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877 [TBL] [Abstract][Full Text] [Related]
33. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp. Kleinpenning MM; van de Kerkhof PC; Gerritsen RM J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288 [TBL] [Abstract][Full Text] [Related]
34. Guidelines of care for the management of actinic keratosis: Executive summary. Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE J Am Acad Dermatol; 2021 Oct; 85(4):945-955. PubMed ID: 34111497 [TBL] [Abstract][Full Text] [Related]
35. New Topical Treatment Options for Actinic Keratosis: A Systematic Review. Stockfleth E; Sibbring GC; Alarcon I Acta Derm Venereol; 2016 Jan; 96(1):17-22. PubMed ID: 26068001 [TBL] [Abstract][Full Text] [Related]
36. Guidelines of care for the management of actinic keratosis. Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE J Am Acad Dermatol; 2021 Oct; 85(4):e209-e233. PubMed ID: 33820677 [TBL] [Abstract][Full Text] [Related]
37. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388 [TBL] [Abstract][Full Text] [Related]
38. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy. Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G; J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789 [TBL] [Abstract][Full Text] [Related]
39. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis. Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546 [TBL] [Abstract][Full Text] [Related]
40. CO2 laser ablative fractional resurfacing photodynamic therapy for actinic keratosis and nonmelanoma skin cancer: a randomized split-side study. Miller MB; Padilla A Cutis; 2020 May; 105(5):251-254. PubMed ID: 32603389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]